scholarly journals Faculty Opinions recommendation of Apatinib for Advanced Osteosarcoma after Failure of Standard Multimodal Therapy: An Open Label Phase II Clinical Trial.

2020 ◽  
Author(s):  
Nathalie Gaspar
Keyword(s):  
Clinical Trial ◽  
Phase Ii ◽  
Multimodal Therapy ◽  
Phase Ii Clinical Trial ◽  
Open Label ◽  
Open Label Phase

scholarly journals Apatinib for Advanced Osteosarcoma after Failure of Standard Multimodal Therapy: An Open Label Phase II Clinical Trial

2019 ◽  
Vol 24 (7) ◽  
Author(s):  
Lu Xie ◽  
Jie Xu ◽  
Xin Sun ◽  
Xiaodong Tang ◽  
Taiqiang Yan ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase Ii ◽  
Multimodal Therapy ◽  
Phase Ii Clinical Trial ◽  
Open Label ◽  
Open Label Phase

REGOMA: A Randomized, Multicenter, Controlled Open-Label Phase II Clinical Trial of Regorafenib Compared to Lomustine in Relapsed Glioblastoma Patients

2018 ◽  
Author(s):  
Giuseppe Lombardi ◽  
Gian Luca De Salvo ◽  
Alba Ariela Brandes ◽  
Marica Eoli ◽  
Roberta Rudà ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase Ii ◽  
Phase Ii Clinical Trial ◽  
Open Label ◽  
Open Label Phase

scholarly journals OS2.3 Updated results of REGOMA: A randomized, multicenter, controlled open-label phase II clinical trial evaluating regorafenib in relapsed glioblastoma patients

2018 ◽  
Vol 20 (suppl_3) ◽  
pp. iii219-iii219
Author(s):  
G Lombardi ◽  
G de Salvo ◽  
R Rudà ◽  
E Franceschi ◽  
M Eoli ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase Ii ◽  
Phase Ii Clinical Trial ◽  
Open Label ◽  
Open Label Phase

scholarly journals A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma

2015 ◽  
Vol 22 (1) ◽  
pp. 61-68 ◽  
Author(s):  
Andrew H. Ko ◽  
Tanios Bekaii-Saab ◽  
Jessica Van Ziffle ◽  
Olga M. Mirzoeva ◽  
Nancy M. Joseph ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Pancreatic Adenocarcinoma ◽  
Phase Ii ◽  
Phase Ii Clinical Trial ◽  
Open Label ◽  
Egfr Inhibition ◽  
Open Label Phase ◽  
Advanced Pancreatic Adenocarcinoma

Tu1448 Intragastric Injection of Botulinum Toxin a to Treat Gastric Cancer: An Open-Label Phase II Clinical Trial

2016 ◽  
Vol 150 (4) ◽  
pp. S1251-S1252
Author(s):  
Gøran Andersen ◽  
Chun-Mei Zhao ◽  
Xing Cai ◽  
Hanne-Line Rabben ◽  
James G. Fox ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Clinical Trial ◽  
Botulinum Toxin ◽  
Phase Ii ◽  
Botulinum Toxin A ◽  
Phase Ii Clinical Trial ◽  
Open Label ◽  
Toxin A ◽  
Open Label Phase

Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The GREKO II study.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. TPS5626-TPS5626
Author(s):  
Alicia Hurtado ◽  
Jesús García-Donas ◽  
Laia Garrigos ◽  
Nuria Laínez ◽  
Andres Redondo ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Granulosa Cell ◽  
Phase Ii ◽  
Ovarian Tumors ◽  
Phase Ii Clinical Trial ◽  
Open Label ◽  
Open Label Phase

scholarly journals Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial

2018 ◽  
Vol 113 (9) ◽  
Author(s):  
Dario Brock Ramalho ◽  
Rosiana Estéfane da Silva ◽  
Maria Camilo Ribeiro de Senna ◽  
Hugo Silva Assis Moreira ◽  
Mariana Junqueira Pedras ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Cutaneous Leishmaniasis ◽  
Phase Ii ◽  
Phase Ii Clinical Trial ◽  
Open Label ◽  
Meglumine Antimoniate ◽  
Open Label Phase
Sign in / Sign up

Export Citation Format

Share Document